NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast cancer



Breast tumor's biological traits guide hormone therapy



June 9th, 2005

The characteristics of an individual patient's breast cancer can help physicians choose the most effective treatment sequence with tamoxifen and the newer aromatase inhibitors, according to a study led by researchers from Dana-Farber Cancer Institute in Boston.

The findings were presented in a poster session at the American Society of Clinical Oncology's annual meeting on May 15, 2005.

Tamoxifen has been used for many years to reduce the risk of recurrence in women following breast cancer treatment. More recently, drugs called aromatase inhibitors that inhibit the production of estrogen in the body have been found highly effective and in some cases...


Source: Women's Health Weekly (2005-06-09)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login